Our vision is to improve the health and general well-being of patients suffering from debilitating and life-altering gastrointestinal conditions in order for them to lead improved lives.
The key components of the S.L.A. Pharma strategy to develop and commercialise new products for gastrointestinal disorders are:

Partnerships are an important component in building on our success and bringing new developments to patients. Current established partnerships cover territories in North, Central and South America, Europe and Australasia. S.L.A. Pharma is seeking partners for various geographic regions and individual countries.